138 related articles for article (PubMed ID: 35552966)
1. Development and Use of an Ex-Vivo In-Vivo Correlation to Predict Antiepileptic Drug Clearance in Patients Undergoing Continuous Renal Replacement Therapy.
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Pharm Res; 2022 May; 39(5):827-836. PubMed ID: 35552966
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy.
Chappell K; Kimmons LA; Haller JT; Canada RB; He H; Hudson JQ
J Crit Care; 2021 Feb; 61():216-220. PubMed ID: 33217623
[TBL] [Abstract][Full Text] [Related]
3. A prospective, real-world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE-02).
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Br J Clin Pharmacol; 2021 Nov; 87(11):4375-4385. PubMed ID: 33855736
[TBL] [Abstract][Full Text] [Related]
4. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Clin Transl Sci; 2020 Sep; 13(5):950-959. PubMed ID: 32223067
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an
Kalaria SN; Kishk OA; Gopalakrishnan M; Bagdure DN
Perfusion; 2022 Nov; 37(8):812-818. PubMed ID: 34192981
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam dosing in patients receiving continuous renal replacement therapy.
Chaijamorn W; Charoensareerat T; Rungkitwattanakul D; Phunpon S; Sathienluckana T; Srisawat N; Pattharachayakul S
Epilepsia; 2021 Sep; 62(9):2151-2158. PubMed ID: 34247386
[TBL] [Abstract][Full Text] [Related]
7. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration.
Franquiz MJ; Kalaria SN; Armahizer MJ; Gopalakrishnan M; McCarthy PJ; Badjatia N
Pharmacotherapy; 2018 Feb; 38(2):e17-e21. PubMed ID: 29160945
[TBL] [Abstract][Full Text] [Related]
9. Acetaminophen clearance during ex vivo continuous renal replacement therapies.
Scoville BA; Vulaj V; Mueller BA; Annich GM; Wagner DS
J Artif Organs; 2018 Jun; 21(2):215-219. PubMed ID: 29063343
[TBL] [Abstract][Full Text] [Related]
10. Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy.
Jang SM; Yessayan L; Dean M; Costello G; Katwaru R; Mueller BA
Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680765
[TBL] [Abstract][Full Text] [Related]
11. Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.
Wei X; Naseer S; Weinstein EA; Iarikov D; Nambiar S; Reynolds KS; Jang SH
Clin Pharmacol Ther; 2022 Nov; 112(5):1004-1007. PubMed ID: 35792715
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide dosing in patients receiving continuous renal replacement therapy.
Chaijamorn W; Phunpon S; Sathienluckana T; Charoensareerat T; Pattharachayakul S; Rungkitwattanakul D; Srisawat N
J Intensive Care; 2023 Nov; 11(1):50. PubMed ID: 37946296
[TBL] [Abstract][Full Text] [Related]
13. Anakinra Removal by Continuous Renal Replacement Therapy: An Ex Vivo Analysis.
Dubinsky SDJ; Watt KM; Imburgia CE; Mcknite AM; Hunt JP; Rice C; Rower JE; Edginton AN
Crit Care Explor; 2023 Dec; 5(12):e1010. PubMed ID: 38107537
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy.
Andrews L; Benken S; Tan X; Wenzler E
BMC Nephrol; 2021 Jan; 22(1):45. PubMed ID: 33516188
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide Pharmacokinetics in a Critically Ill Patient During Continuous Renal Replacement Therapy.
Wieruszewski PM; Lopez-Ruiz A; Albright RC; Fugate JE; Barreto EF
J Pharm Pract; 2020 Jun; 33(3):395-398. PubMed ID: 30336720
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.
Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A
Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703
[TBL] [Abstract][Full Text] [Related]
17. Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results.
Dorshow RB; Johnson JR; Shieh JJ; Riley IR; Rogers TE; Pino CJ; Johnston KA; Tang P; Nolin TD; Humes HD; Goldstein SL
ASAIO J; 2023 Jul; 69(7):708-715. PubMed ID: 37097973
[TBL] [Abstract][Full Text] [Related]
18. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic Drug Removal by Continuous Renal Replacement Therapy: A Review of the Literature.
Mahmoud SH
Clin Drug Investig; 2017 Jan; 37(1):7-23. PubMed ID: 27587068
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
